Oscar Health, Inc. P/EBITDA LTM
| Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|
| P/EBITDA LTM | (3.1x) | (1.0x) | (7.1x) | 36.3x |
Oscar Health, Inc. (OSCR) P/EBITDA LTM comparison analysis
General
LTM P/EBITDA LTM
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
OSCR key stats
| Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|
% growth | 553.8 0.0% | 589.6 6.5% | 1,921.0 225.8% | 4,125.6 114.8% | 5,862.9 42.1% | 9,177.6 56.5% |
| Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
% margin | 553.8 100.0% | 589.6 100.0% | 1,921.0 100.0% | 4,125.6 100.0% | 5,862.9 100.0% | 9,177.6 100.0% |
| Operating Expenses | (814.2) | (996.5) | (2,498.0) | 4,553.5 | 6,098.5 | 9,120.3 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 110.7 | 166.7 | 265.1 | 309.8 | 339.7 | 1,755.9 |
% margin | (260.5) (47.0%) | (406.9) (69.0%) | (577.1) (30.0%) | (584.2) (14.2%) | (235.6) (4.0%) | 57.3 0.6% |
| Interest Income | 11.1 | 8.0 | 10.3 | 31.3 | 0.0 | 0.0 |
| Interest Expense | 0.0 | 3.5 | 4.7 | 22.6 | 24.6 | 23.7 |
| Pre-tax Income | (259.4) | (405.8) | (570.6) | (610.1) | (267.3) | 33.4 |
% effective tax rate | 1.8 (0.7%) | 1.0 (0.3%) | 0.8 (0.1%) | (0.5) 0.1% | 3.3 (1.2%) | 7.3 21.9% |
% margin | (261.2) (47.2%) | (406.8) (69.0%) | (571.4) (29.7%) | (609.6) (14.8%) | (270.7) (4.6%) | 25.4 0.3% |
| EPS | (1.09) | (1.70) | (3.19) | (2.87) | (1.22) | 0.11 |
| Diluted EPS | (1.09) | (1.70) | (3.19) | (2.87) | (1.22) | 0.10 |
% margin | (252.5) (45.6%) | (391.0) (66.3%) | (551.3) (28.7%) | (572.2) (13.9%) | (212.0) (3.6%) | 88.6 1.0% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
FAQ
1) What is Oscar Health, Inc.'s P/EBITDA LTM?
As of today, Microsoft Corp's last 12-month P/EBITDA LTM is 36.3x, based on the financial report for Dec 30, 2024 (Q4’2024). The average annual P/EBITDA LTM for Oscar Health, Inc. have been 38.6x over the past three years, and 28.6x over the past five years.
2) Is Oscar Health, Inc.'s P/EBITDA LTM Good?
As of today, Oscar Health, Inc.'s P/EBITDA LTM is 36.3x, which is higher than industry median of 6.0x. It indicates that Oscar Health, Inc.'s P/EBITDA LTM is Bad.